MORRISVILLE, N.C., Oct. 21, 2022 (GLOBE NEWSWIRE) — Syneos Health®SYNCHthe only fully integrated biopharmaceutical solutions company, will report its third quarter 2022 financial results on Friday, November 4, 2022 prior to its conference call at 8:00 a.m. ET.
To listen and view the presentation slides via the live webcast only, log in to the Investor Relations section of the Syneos Health website at investor.syneoshealth.com.
To participate in the conference, please register in advance shortcut. After registering, all attendees will receive a confirmation email with details on how to join the conference call, including dial-in number along with a unique passcode and registration ID that can be used to access the conference call.
A replay of the webcast will be available on the Investor Relations section of Syneos Health’s website at investor.syneoshealth.com after 1:00 p.m. on November 4, 2022.
About Syneos Health
Syneos health®SYNCH is the only fully integrated biopharmaceutical solutions company purpose-built to accelerate customer success. We lead with a product development mindset, strategically integrating clinical development, medical affairs and commercial capabilities to meet modern market realities.
We bring together more than 29,000 minds in more than 110 countries that have a deep understanding of patient and physician behavior and market dynamics. Together, we share insights, leverage the latest technologies and apply advanced business practices to accelerate our customers’ delivery of critical therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares about colleagues, customers, patients, communities and the environment.
To learn more about how we are shortening the journey from lab to life®Visit syneoshealth.com or subscribe to our podcast.
